X

Xaira Therapeutics

AI-powered protein design for therapeutics

Principal Scientist - Target Discovery & Portfolio Strategy

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USAIn-person

About the Job

Requirements

  • A PhD in immunology or a related field and 6+ years of industry experience in drug discovery, target discovery, preclinical drug development, or translational drug development.
  • Experience using human genetics, genome-scale multi-omics datasets, and other human data alongside cell biology, disease biology, and clinical findings to evaluate therapeutic hypotheses.
  • Strong scientific judgment and the ability to distinguish an interesting association from a credible therapeutic opportunity.
  • Clear communication skills and the ability to guide decisions across disciplines.
  • Curiosity, independence, and a willingness to challenge assumptions and revise recommendations as the evidence evolves.

Responsibilities

  • Identify promising disease areas by assessing unmet needs, disease mechanisms, patient subsets, and limitations of current treatments.
  • Find and prioritize targets by combining human genetics, functional genomics, genome-scale multi-omics datasets, and patient data to develop therapeutic hypotheses.
  • Assess platform fit with molecular design, protein engineering, and functional screening teams to identify opportunities where the platforms could offer a therapeutic advantage.
  • Evaluate causality, the desired direction of target modulation, safety risks, and key knowledge gaps.
  • Develop concise target assessments covering disease rationale, patient selection, competition, differentiation, and risks.
  • Track emerging science and competition by following publications and clinical results and monitoring the competitive landscape to identify opportunities and inform priorities.
  • Use AI tools to analyze multi-modal data.
  • Lead discovery programs or platform initiatives.

About the Company

Xaira Therapeutics

AI-powered protein design for therapeutics

Xaira Therapeutics uses artificial intelligence to transform drug discovery and development. It builds a pipeline of protein- and antibody-based therapeutics by combining generative AI models from the IPD lab (notably RFdiffusion and RFantibody) with large, multidimensional biological data. The company designs novel proteins and antibodies from scratch to target difficult, previously undruggable biology, then validates and evolves these molecules through iterative data generation that improves its biological foundation models. Unlike many entrants that offer research services, Xaira aims to own and advance its own therapeutic pipeline across multiple modalities, rather than solely providing platforms. The goal is to deliver effective new medicines faster and with a lower chance of failure by integrating AI-driven design, expansive data, and expert leadership.

Company size
201-500
Company stage
Late Stage VC
Total funding
$1B
Headquarters
South San Francisco, CA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Xaira Therapeutics

See more jobs